ACCOUNTS - Final Accounts


Caseware UK (AP4) 2021.0.152 2021.0.152 2021-07-312021-07-312020-08-01falseNo description of principal activitytruetrueThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006. 09840516 2020-08-01 2021-07-31 09840516 2019-08-01 2020-07-31 09840516 2021-07-31 09840516 2020-07-31 09840516 c:Director2 2020-08-01 2021-07-31 09840516 d:Buildings d:LongLeaseholdAssets 2020-08-01 2021-07-31 09840516 d:Buildings d:LongLeaseholdAssets 2021-07-31 09840516 d:Buildings d:LongLeaseholdAssets 2020-07-31 09840516 d:LeaseholdInvestmentProperty 2020-08-01 2021-07-31 09840516 d:LeaseholdInvestmentProperty 2021-07-31 09840516 d:LeaseholdInvestmentProperty 2020-07-31 09840516 d:LeaseholdInvestmentProperty 2 2020-08-01 2021-07-31 09840516 d:CurrentFinancialInstruments 2021-07-31 09840516 d:CurrentFinancialInstruments 2020-07-31 09840516 d:Non-currentFinancialInstruments 2021-07-31 09840516 d:Non-currentFinancialInstruments 2020-07-31 09840516 d:CurrentFinancialInstruments d:WithinOneYear 2021-07-31 09840516 d:CurrentFinancialInstruments d:WithinOneYear 2020-07-31 09840516 d:Non-currentFinancialInstruments d:AfterOneYear 2021-07-31 09840516 d:Non-currentFinancialInstruments d:AfterOneYear 2020-07-31 09840516 d:ShareCapital 2021-07-31 09840516 d:ShareCapital 2020-07-31 09840516 d:RetainedEarningsAccumulatedLosses 2021-07-31 09840516 d:RetainedEarningsAccumulatedLosses 2020-07-31 09840516 c:OrdinaryShareClass1 2020-08-01 2021-07-31 09840516 c:OrdinaryShareClass1 2021-07-31 09840516 c:OrdinaryShareClass1 2020-07-31 09840516 c:FRS102 2020-08-01 2021-07-31 09840516 c:Audited 2020-08-01 2021-07-31 09840516 c:FullAccounts 2020-08-01 2021-07-31 09840516 c:PrivateLimitedCompanyLtd 2020-08-01 2021-07-31 09840516 c:SmallCompaniesRegimeForAccounts 2020-08-01 2021-07-31 09840516 4 2020-08-01 2021-07-31 09840516 d:AcceleratedTaxDepreciationDeferredTax 2021-07-31 09840516 d:AcceleratedTaxDepreciationDeferredTax 2020-07-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 09840516









AGINCARE (CASTLETOWN) LIMITED









FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 JULY 2021

 
AGINCARE (CASTLETOWN) LIMITED
REGISTERED NUMBER: 09840516

BALANCE SHEET
AS AT 31 JULY 2021

2021
2020
Note
£
£

Fixed assets
  

Tangible assets
 4 
314,704
-

Investment property
 5 
265,296
265,794

  
580,000
265,794

Current assets
  

Debtors: amounts falling due within one year
 6 
16,856
22,245

Cash at bank and in hand
 7 
4,406
4,643

  
21,262
26,888

Creditors: amounts falling due within one year
 8 
(987,109)
(337,776)

Net current liabilities
  
 
 
(965,847)
 
 
(310,888)

Total assets less current liabilities
  
(385,847)
(45,094)

Creditors: amounts falling due after more than one year
 9 
(64,849)
-

Provisions for liabilities
  

Deferred tax
 10 
(16,781)
-

  
 
 
(16,781)
 
 
-

Net liabilities
  
(467,477)
(45,094)


Capital and reserves
  

Called up share capital 
 11 
100
100

Profit and loss account
  
(467,577)
(45,194)

  
(467,477)
(45,094)


The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 29 July 2022.


Page 1

 
AGINCARE (CASTLETOWN) LIMITED
REGISTERED NUMBER: 09840516
    
BALANCE SHEET (CONTINUED)
AS AT 31 JULY 2021



R M Taylor-Summerson
Director

Page 2

 
AGINCARE (CASTLETOWN) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2021

1.


General information

Agincare (Castletown) Limited is a private company limited by shares. The company was incorporated in the United Kingdom and is registered in England and Wales. The registered office address is Agincare House Admiralty Buildings, Castletown, Portland, Dorset, United Kingdom, DT5 1BB.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Section 1A of Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The following principal accounting policies have been applied:

 
2.2

Going concern

At the year end, the company had net liabilities and incurred a loss after tax. The company has now commenced trading and receives income which is sufficient to cover the operational costs of the business. As a result, the directors consider it appropriate to prepare the accounts on a going concern basis.
The directors are satisfied that the going concern assessment is passed despite the impact of Covid-19, and consider the company remains in a strong position for the future.

 
2.3

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
AGINCARE (CASTLETOWN) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2021

2.Accounting policies (continued)

 
2.4

Current and deferred taxation

The tax expense for the year comprises current and deferred tax. Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company operates and generates income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the Balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

 
2.5

Exceptional items

Exceptional items are transactions that fall within the ordinary activities of the Company but are presented separately due to their size or incidence.

 
2.6

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Land is not depreciated. Depreciation on other assets is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Long-term leasehold property
-
2%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Depreciation commences when the asset is available for use.

Page 4

 
AGINCARE (CASTLETOWN) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2021

2.Accounting policies (continued)

 
2.7

Investment property

Investment property is carried at fair value determined annually by external valuers and derived from the current market rents and investment property yields for comparable real estate, adjusted if necessary for any difference in the nature, location or condition of the specific asset. No depreciation is provided. Changes in fair value are recognised in profit or loss.

 
2.8

Debtors

Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

 
2.9

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.10

Creditors

Short term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.11

Provisions for liabilities

Provisions are made where an event has taken place that gives the Company a legal or constructive obligation that probably requires settlement by a transfer of economic benefit, and a reliable estimate can be made of the amount of the obligation.
Provisions are charged as an expense to profit or loss in the year that the Company becomes aware of the obligation, and are measured at the best estimate at the balance sheet date of the expenditure required to settle the obligation, taking into account relevant risks and uncertainties.
When payments are eventually made, they are charged to the provision carried in the Balance sheet.

 
2.12

Financial instruments

The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.

Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently, at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short-term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or in case of an out-right short-term loan that is not at market rate, the financial asset or liability is measured, initially at the present value of future cash flows discounted at a market rate of interest for a similar debt
Page 5

 
AGINCARE (CASTLETOWN) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2021

2.Accounting policies (continued)


2.12
Financial instruments (continued)

instrument and subsequently at amortised cost, unless it qualifies as a loan from a director in the case of a small company, or a public benefit entity concessionary loan.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in the Statement of income and retained earnings.

For financial assets measured at amortised cost, the impairment loss is measured as the difference between an asset's carrying amount and the present value of estimated cash flows discounted at the asset's original effective interest rate. If a financial asset has a variable interest rate, the discount rate for measuring any impairment loss is the current effective interest rate determined under the contract.

For financial assets measured at cost less impairment, the impairment loss is measured as the difference between an asset's carrying amount and best estimate of the recoverable amount, which is an approximation of the amount that the Company would receive for the asset if it were to be sold at the balance sheet date.

Financial assets and liabilities are offset and the net amount reported in the Balance sheet when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.


3.


Employees

The average monthly number of employees, including directors, during the year was 2 (2020 - 2).

Page 6

 
AGINCARE (CASTLETOWN) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2021

4.


Tangible fixed assets





Long-term leasehold property

£



Cost or valuation


Additions
536,379


Impairment charge
(221,675)



At 31 July 2021

314,704






Net book value



At 31 July 2021
314,704



At 31 July 2020
-

Long-term leasehold property includes land valued at £164,407 which is not depreciated. 
Capital expenditure on the long-term leasehold property is covered by the capital goods scheme (CGS). The scheme requires adjustments to be made to the initial amount of VAT claimed that reflects the differences in the use of capital items over a period of time.

Page 7

 
AGINCARE (CASTLETOWN) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2021

5.


Investment property


Long term leasehold investment property

£



Valuation


At 1 August 2020
265,794


Additions at cost
186,374


Impairment charge 
(186,872)



At 31 July 2021
265,296

The 2021 valuations were made on an open market value for existing use basis. The directors consider the valuation of the long term leasehold investment property is appropriate having taken into account current market rents and investment property yields for comparable real estate








Page 8

 
AGINCARE (CASTLETOWN) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2021

6.


Debtors

2021
2020
£
£


Amounts owed by group undertakings
15,055
2,727

Other debtors
100
19,518

Prepayments and accrued income
1,701
-

16,856
22,245



7.


Cash and cash equivalents

2021
2020
£
£

Cash at bank and in hand
4,406
4,643

4,406
4,643



8.


Creditors: Amounts falling due within one year

2021
2020
£
£

Trade creditors
482
628

Amounts owed to group undertakings
978,201
334,648

Other taxation and social security
5,925
-

Accruals and deferred income
2,501
2,500

987,109
337,776



9.


Creditors: Amounts falling due after more than one year

2021
2020
£
£

Other taxation and social security
64,849
-

64,849
-


Page 9

 
AGINCARE (CASTLETOWN) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2021

10.


Deferred taxation




2021


£






Charged to profit or loss
(16,781)



At end of year
(16,781)

The deferred taxation balance is made up as follows:

2021
2020
£
£


Accelerated capital allowances
(16,781)
-

(16,781)
-


11.


Share capital

2021
2020
£
£
Allotted, called up and fully paid



100 (2020 - 100) Ordinary shares of £1.00 each
100
100



12.


Related party transactions

The company has taken advantage of the exemptions from some of the requirements in Section 33 Related Party Disclosures from disclosing transactions with other members of the group.


13.


Controlling party

The immediate parent company is Agincare Homes Holdings Limited, a company registered in England and Wales, by virtue of its 100% holding of the Ordinary share capital of Agincare (Castletown) Limited. The ultimate parent company is Agincare Holdings Limited, a company registered in England and Wales, by virtue of its 100% holding of the Ordinary share capital of Agincare Homes Holdings Limited. The ultimate controlling party is Mr D E Luckhurst, by virtue of his majority shareholding in Agincare Holdings Limited.
Group financial statements are prepared by Agincare Holdings Limited and copies can be obtained from Agincare House, Admiralty Buildings, Castletown, Portland, Dorset, DT5 1BB.

Page 10

 
AGINCARE (CASTLETOWN) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2021

14.


Auditors' information

The auditors' report on the financial statements for the year ended 31 July 2021 was unqualified.

The audit report was signed on 29 July 2022 by Daniel Reid FCA (Senior statutory auditor) on behalf of Donald Reid Limited.

 
Page 11